The Mitochondrial DNA Control Region Might Have Useful Diagnostic and Prognostic Biomarkers for Thyroid Tumors
Autor: | Cenk Aral, Sukran Sarikaya, Serhat Özçelik, Hulya Iliksu Gozu, Aylin Ege Gul, Rifat Bircan, Esra Ulu, Duygu Yasar Sirin |
---|---|
Přispěvatelé: | Bircan, Rifat, Gozu, Hulya Iliksu, Ulu, Esra, Sarikaya, Sukran, Gul, Aylin Ege, Sirin, Duygu Yasar, Ozcelik, Serhat, Aral, Cenk |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Identification endocrine system diseases Endocrinology Diabetes and Metabolism mitochondrial DNA D-LOOP REGION medicine.disease_cause Haplogroup Papillary thyroid cancer 0302 clinical medicine Endocrinology Thyroid cancer POPULATION Nodules D310 Thyroid Instability T16189C General Medicine control region D514 CA repeat medicine.anatomical_structure thyroid nodule MOLECULAR PATHOGENESIS Mutations Receptor Thyroid nodules Mitochondrial DNA Evolution Population INSTABILITY 030209 endocrinology & metabolism Single-nucleotide polymorphism Biology Thyroid carcinoma 03 medical and health sciences NODULES Germline mutation Internal Medicine medicine D-Loop Region papillary thyroid cancer POLYMORPHISMS RECEPTOR IDENTIFICATION MUTATIONS medicine.disease Molecular Pathogenesis EVOLUTION 030104 developmental biology Tumor progression Cancer research Polymorphisms Carcinogenesis Human mitochondrial DNA haplogroup |
Zdroj: | Experimental and Clinical Endocrinology & Diabetes. 127:423-436 |
ISSN: | 1439-3646 0947-7349 |
DOI: | 10.1055/a-0869-7355 |
Popis: | BackgroundIt is currently present in the literature that mitochondrial DNA (mtDNA) defects are associated with a great number of diseases including cancers. The role of mitochondrial DNA (mtDNA) variations in the development of thyroid cancer is a highly controversial topic. In this study, we investigated the role of mt-DNA control region (CR) variations in thyroid tumor progression and the influence of mtDNA haplogroups on susceptibility to thyroid tumors.Material & methodFor this purpose, totally 108 hot thyroid nodules (HTNs), 95 cold thyroid nodules (CTNs), 48 papillary thyroid carcinoma (PTC) samples with their surrounding tissues and 104 healthy control subject’s blood samples were screened for entire mtDNA CR variations by using Sanger sequencing. The obtained DNA sequences were anaysed with the mistomaster, a web-based bioinformatics tool.ResultsMtDNA haplogroup U was significantly associated with susceptibility to benign and malign thyroid entities on the other hand J haplogroup was associated with a protective role for benign thyroid nodules. Besides, 8 SNPs (T146C, G185A, C194T, C295T, G16129A, T16304C, A16343G and T16362C) in mtDNA CR region were associated with the occurrence of benign and malign thyroid nodules in Turkish population. By contrast with the healthy Turkish population and HTNs, frequency of C7 repeats in D310 polycytosine sequence was found higher in cold thyroid nodules and PTC samples. Beside this, the frequency of somatic mutations in mtMSI regions including T16189C and D514 CA dinucleotide repeats were found higher in PTC samples than the benign thyroid nodules. Conversely, the frequency of somatic mutations in D310 was detected higher in HTNs than CTNs and PTCs.ConclusionmtDNA D310 instability do not play a role in tumorogenesis of the PTC but the results indicates that it might be used as a diagnostic clonal expansion biomarker for premalignant thyroid tumor cells. Beside this, D514 CA instability might be used as prognostic biomarker in PTCs. Also, we showed that somatic mutation rate is less frequent in more aggressive tumors when we examined micro- and macro carcinomas as well as BRAFV600E mutation. |
Databáze: | OpenAIRE |
Externí odkaz: |